IGF1 and malignant mesothelioma: On the basis of previous studies showing that IGF-I triggers stimulatory effects in malignant mesothelioma as well as in lung cancer cells [31-32], we began our study evaluating the transduction signaling activated by IGF-I in IST-MES1 mesothelioma and A549 lung cancer cells, which were used as model system.